Short Interest in Halberd Co. (OTCMKTS:HALB) Rises By 22.0%

Halberd Co. (OTCMKTS:HALB – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totalling 68,700 shares, a growth of 22.0% from the September 30th total of 56,300 shares. Based on an average trading volume of 2,643,800 shares, the short-interest ratio is currently 0.0 days.

Halberd Price Performance

HALB remained flat at $0.00 during trading on Wednesday. 335,700 shares of the company traded hands, compared to its average volume of 1,169,286. The stock has a fifty day moving average of $0.01 and a 200-day moving average of $0.01. Halberd has a 1 year low of $0.00 and a 1 year high of $0.01.

Halberd Company Profile

(Get Free Report)

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Featured Articles

• Five stocks we like better than Halberd
• Dividend Capture Strategy: What You Need to Know
• Boeing: Why Analysts Think Now’s The Time To Be Brave
• Natural Gas Prices Continue To Rally, These Stocks Should Benefit
• Advanced Micro Devices is Building Momentum with AI: Buy the Dip
• What Do S&P 500 Stocks Tell Investors About the Market?
• Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?